Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Alnylam Pharmaceuticals Inc

+ Add to Watchlist

ALNY:US

99.6500 USD 4.7700 4.57%

As of 10:08:22 ET on 04/01/2015.

Snapshot for Alnylam Pharmaceuticals Inc (ALNY)

Open: 103.7600 Day's Range: 99.3900 - 104.3700 Volume: 103,691
Previous Close: 104.4200 52wk Range: 47.0300 - 121.9300 1-Yr Rtn: +47.74%

Stock Chart for ALNY

No chart data available.
  • ALNY:US 99.6500
  • 1D
  • 1M
  • 1Y
104.4200
Interactive ALNY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALNY

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.8803
Est. EPS (USD) (12/2015) -2.9340
Est. PEG Ratio -
Market Cap (M USD) 8,746.23
Shares Outstanding (M) 83.76
30 Day Average Volume 659,493
Price/Book (mrq) 8.2145
Price/Sale (ttm) 147.8090
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALNY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ALNY

Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.

John M MaraganoreChief Executive OfficerBarry E GreenePresident/COO
Akshay K VaishnawExec VP:Research & DevLaurie Bartlett KeatingSenior VP/Secretary/Gen Cnsl
More Company Profile & Key Executives for ALNY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil